サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1757988

自家ワクチンの世界市場

Autogenous Vaccines

出版日
ページ情報
英文 266 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.48円
自家ワクチンの世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 266 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自家ワクチンの世界市場は2030年までに1億7,340万米ドルに達する見込み

2024年に1億4,000万米ドルと推定される自家ワクチンの世界市場は、2030年には1億7,340万米ドルに達し、分析期間2024～2030年のCAGRは3.6%で成長すると予測されます。本レポートで分析したセグメントの1つである細菌株は、CAGR 2.9％を記録し、分析期間終了時には1億860万米ドルに達すると予測されます。ウイルス株セグメントの成長率は、分析期間でCAGR 4.9％と推定されます。

米国市場は3,820万米ドルと推定される一方、中国はCAGR 6.6％で成長すると予測される

米国の自家ワクチン市場は、2024年には3,820万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 6.6%で推移し、2030年には予測市場規模3,450万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5％と2.8％と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の自家ワクチン市場- 主要動向と促進要因のまとめ

なぜ自家ワクチンは獣医学および農業保健における戦略的関連性を高めているのか？

自家ワクチンは、特に獣医・畜産業界において、地域特異的・群特異的な感染症との闘いに不可欠な要素として浮上してきました。広く使用されるために開発された従来のワクチンとは異なり、自家ワクチンは特定の農場や動物集団から分離された病原体を使用して調整され、的を絞った非常に効果的な疾病対策を提供します。このカスタマイズされたアプローチは、市販のワクチンが存在しない場合や、微生物の変異により既存のワクチンが効果を失った場合に特に重要です。抗菌薬耐性（AMR）の蔓延は、動物の予防ヘルスケアへのシフトにも拍車をかけており、自家ワクチンはその中心的役割を担っています。米国、ドイツ、フランスなどの国々では、家畜への抗生物質の使用を制限する厳しい規制が導入され、感染症を未然に防ぐワクチンの需要が高まっています。さらに、農家や獣医師は、生産性の低下、治療費の増加、貿易制限など、家畜の疾病が経済的に与える影響についてますます認識するようになっています。このような意識の高まりと、局所的な有効性でより迅速な予防接種サイクルを実現する自家ワクチンの能力が相まって、市場の成長を牽引しています。

規制環境と動物用ヘルスケアインフラは市場拡大にどのような影響を与えているか？

自家ワクチンの規制状況は大きく進化しています。USDA Center for Veterinary Biologics（米国獣医生物製剤センター）やEMA（欧州医薬品庁）のような規制機関は、自家ワクチンの承認プロセスを合理化し、新興および流行の動物疾病に取り組む上での重要性を認識しています。こうした規制の枠組みは、安全性と有効性を確保すると同時に、市販ワクチンに比べて迅速な市場参入を可能にし、より広範な使用を促しています。さらに、アジア太平洋やラテンアメリカを中心とした新興国地域の獣医療インフラが強化されたことで、自家ワクチン製造業者にとって新たな市場が開拓されました。ブラジルやインドのような国々は、畜産と獣医学研究に多大な投資を行っており、それによってこれらのワクチンの潜在的応用基盤を拡大しています。制度面では、研究機関、製薬会社、畜産協同組合間の協力関係の強化が、新しい自家製剤の開発を加速させています。さらに、政府が支援する疾病サーベイランス・プログラムによって、新たに出現する病原体の早期発見が可能となり、牛群に特異的なワクチンの迅速な製造が可能となっています。事実、規制当局の支援、インフラの改善、共同研究イニシアチブの組み合わせが、市場拡大の強力な触媒として機能しています。

需要の形成において、家畜経済とバイオセキュリティはどのような役割を果たしているのか？

家畜は、特に人口の大部分が畜産に依存している新興経済諸国において、世界の食料安全保障、所得創出、貿易において重要な役割を果たしています。家畜の間で病気が発生すると、収穫量の損失、輸出禁止、治療費の高騰など、経済的に壊滅的な影響を及ぼす可能性があるため、農家は積極的な病気予防戦略への投資を増やしています。自家ワクチンは、そのカスタマイズ性と迅速な利用可能性により、バイオセキュリティプロトコルにおける戦略的優位性を提供します。さらに、世界の集約型農業の動向は疾病伝播のリスクを高めており、精密ワクチン接種が不可欠なツールとなっています。食肉、酪農、家禽の輸出が増加する中、各国は国際的な衛生基準を満たし、貿易の混乱を避けるためにバイオセキュリティ対策を強化しています。多様な水生病原体やさまざまな養殖場条件のために、従来のワクチンでは不十分なことが多い水産養殖においても、自家ワクチンは普及しつつあります。オーダーメイドの予防接種ソリューションによって健康な牛群を維持するという経済的論理が、大規模な農業関連企業に現場専用のワクチン開発施設への投資を促し、市場への浸透をさらに高めています。このように、自家ワクチンを農場レベルの健康管理システムに組み込むことは、選択肢というよりもむしろ必要不可欠なものとなりつつあります。

自家ワクチン市場の成長はいくつかの要因によって牽引されている...

自家ワクチン市場の成長軌道は、技術的、農業的、行動的シフトのユニークな相互作用によって後押しされています。主な原動力のひとつは、病原体の同定と分子診断の進歩であり、自家ワクチンの開発にかかる時間とコストを大幅に削減しました。農場記録のデジタル化と優れた疾病追跡システムにより、疾病原因物質の迅速な分離が可能になり、迅速な処方が促進されています。第二に、精密畜産の動向の高まりにより、疾病予測モデリングに基づくタイムリーなワクチン配備を知らせることができるデータ駆動型ツールの普及が進んでいます。第三に、人獣共通感染症の世界の増加により、動物からヒトへの感染リスクに対する意識が高まり、農場レベルでの衛生管理がより厳しくなっています。第四に、大規模な畜産経営では、包括的な牛群衛生計画の一環として、個別ワクチンの使用を義務付けるバイオセキュリティの枠組みを採用する傾向が強まっています。第五に、抗生物質不使用の食肉や乳製品を求める消費者の要求により、生産者はコンプライアンスと製品の完全性の両方を確保するために、自家ワクチンのような代替品を求めざるを得なくなっています。第六に、特に家禽、養豚、水産養殖セクターにおいて、スケーラブルな自家ワクチン製造プラットフォームの開発に焦点を当てた研究開発投資や官民パートナーシップが顕著に増加しています。これらの要因は、技術、規制、消費者行動にわたって集約され、総体的に自家ワクチン市場のダイナミックな成長を支えています。

セグメント

菌株タイプ（細菌株、ウイルス株）、動物タイプ（家禽、豚、魚、馬、その他の動物タイプ）、エンドユーザー（獣医研究所エンドユーザー、畜産会社エンドユーザー、動物病院＆クリニックエンドユーザー）

調査対象企業の例（全32社）

  • ACE Laboratory Services
  • Addison Biological Laboratory
  • AniCon Labor GmbH
  • Boehringer Ingelheim
  • Cambridge Technologies
  • Ceva Sante Animale
  • Deltamune
  • Dyntec s.r.o.
  • Elanco Animal Health
  • Genova Labs
  • HIPRA
  • Huvepharma
  • Hygieia Biological Laboratories
  • Merck Animal Health
  • Newport Laboratories
  • Phibro Animal Health Corporation
  • Sanphar（IPEVE）
  • Vaxxinova
  • Virbac
  • Zoetis Inc.

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36232

Global Autogenous Vaccines Market to Reach US$173.4 Million by 2030

The global market for Autogenous Vaccines estimated at US$140.0 Million in the year 2024, is expected to reach US$173.4 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Bacterial Strain, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$108.6 Million by the end of the analysis period. Growth in the Virus Strain segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$38.2 Million While China is Forecast to Grow at 6.6% CAGR

The Autogenous Vaccines market in the U.S. is estimated at US$38.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$34.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Autogenous Vaccines Market - Key Trends & Drivers Summarized

Why Are Autogenous Vaccines Gaining Strategic Relevance in Veterinary and Agricultural Health?

Autogenous vaccines have emerged as a vital component in the fight against region-specific and herd-specific infections, particularly within the veterinary and livestock industries. Unlike conventional vaccines, which are developed for widespread use, autogenous vaccines are tailored using pathogens isolated from a specific farm or animal population, providing targeted and highly effective disease control. This customized approach is especially crucial in cases where no commercial vaccine exists or where existing vaccines have lost effectiveness due to microbial mutations. The increasing prevalence of antimicrobial resistance (AMR) has also spurred a shift toward preventive healthcare in animals, with autogenous vaccines playing a central role. Countries such as the U.S., Germany, and France have introduced stricter regulations limiting the use of antibiotics in livestock, thereby boosting demand for vaccines that can prevent infections proactively. Moreover, farmers and veterinarians are becoming increasingly aware of the economic impact of animal diseases, including reduced productivity, higher treatment costs, and trade restrictions. This growing awareness, combined with the ability of autogenous vaccines to deliver faster immunization cycles with localized efficacy, is driving the growth of the market.

How Is the Regulatory Environment and Veterinary Healthcare Infrastructure Influencing Market Expansion?

The regulatory landscape for autogenous vaccines is undergoing significant evolution. Regulatory bodies like the USDA Center for Veterinary Biologics and the European Medicines Agency (EMA) have established streamlined approval processes for autogenous vaccines, recognizing their importance in tackling emerging and endemic animal diseases. These regulatory frameworks, while ensuring safety and efficacy, also facilitate quicker market entry compared to commercial vaccines, encouraging more widespread usage. Additionally, the strengthening of veterinary healthcare infrastructure across developing regions, particularly in Asia-Pacific and Latin America, has opened up new markets for autogenous vaccine producers. Countries like Brazil and India are making significant investments in animal husbandry and veterinary research, thereby expanding the potential application base for these vaccines. On the institutional front, increasing collaboration between research institutions, pharmaceutical companies, and livestock cooperatives is accelerating the development of new autogenous formulations. This is further complemented by government-backed disease surveillance programs that help identify emerging pathogens early, enabling faster formulation of herd-specific vaccines. In effect, a combination of regulatory support, improved infrastructure, and cooperative research initiatives is acting as a strong catalyst for market expansion.

What Role Does Livestock Economics and Biosecurity Play in Shaping Demand?

Livestock plays a critical role in global food security, income generation, and trade, especially in developing economies where a significant portion of the population depends on animal agriculture. As disease outbreaks among livestock can have devastating economic consequences-including loss of yield, export bans, and rising treatment costs-farmers are increasingly investing in proactive disease prevention strategies. Autogenous vaccines, by virtue of their customization and faster availability, provide a strategic advantage in biosecurity protocols. Moreover, the global trend toward intensive farming practices has elevated the risk of disease transmission, making precision vaccination an indispensable tool. With growing exports of meat, dairy, and poultry, countries are tightening biosecurity measures to meet international health standards and avoid trade disruptions. Autogenous vaccines are also becoming popular in aquaculture, where traditional vaccines often fall short due to diverse aquatic pathogens and varying farm conditions. The economic logic of maintaining healthy herds through tailored immunization solutions is prompting larger agribusinesses to invest in dedicated on-site vaccine development facilities, further increasing market penetration. Thus, the integration of autogenous vaccines into farm-level health management systems is becoming more of a necessity than an option.

The Growth in the Autogenous Vaccines Market Is Driven by Several Factors…

The market's upward trajectory is fueled by a unique interplay of technological, agricultural, and behavioral shifts. One of the primary drivers is the advancement in pathogen identification and molecular diagnostics, which has significantly reduced the time and cost of developing autogenous vaccines. The digitization of farm records and better disease tracking systems enable faster isolation of disease-causing agents, facilitating rapid formulation. Secondly, the rising trend of precision livestock farming has led to the widespread use of data-driven tools that can inform timely vaccine deployment based on predictive disease modeling. Third, the global rise in zoonotic disease outbreaks has heightened awareness about animal-to-human transmission risks, incentivizing stricter farm-level health controls. Fourth, large-scale animal farming operations are increasingly adopting biosecurity frameworks that mandate the use of customized vaccines as part of comprehensive herd health plans. Fifth, consumer demand for antibiotic-free meat and dairy products has compelled producers to seek alternatives such as autogenous vaccines to ensure both compliance and product integrity. Sixth, there is a marked increase in R&D investments and public-private partnerships focused on developing scalable autogenous vaccine manufacturing platforms, especially for poultry, swine, and aquaculture sectors. These factors, converging across technology, regulation, and consumer behavior, collectively underpin the dynamic growth of the autogenous vaccines market.

SCOPE OF STUDY:

The report analyzes the Autogenous Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Strain Type (Bacterial Strain, Virus Strain); Animal Type (Poultry, Swine, Fish, Horses, Other Animal Types); End-Use (Veterinary Research Institutes End-Use, Livestock Farming Companies End-Use, Veterinary Clinics & Hospitals End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ACE Laboratory Services
  • Addison Biological Laboratory
  • AniCon Labor GmbH
  • Boehringer Ingelheim
  • Cambridge Technologies
  • Ceva Sante Animale
  • Deltamune
  • Dyntec s.r.o.
  • Elanco Animal Health
  • Genova Labs
  • HIPRA
  • Huvepharma
  • Hygieia Biological Laboratories
  • Merck Animal Health
  • Newport Laboratories
  • Phibro Animal Health Corporation
  • Sanphar (IPEVE)
  • Vaxxinova
  • Virbac
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Autogenous Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Zoonotic and Livestock Diseases Generates Demand for Custom Vaccines
    • Shift Toward Precision Veterinary Medicine Strengthens Business Case for Autogenous Vaccines
    • Rising Restrictions on Antibiotics in Animal Husbandry Drive Adoption of Vaccination Programs
    • Growing Awareness of Animal Health and Biosecurity Measures Spurs Market Growth
    • Increasing Regulatory Acceptance for Custom Formulations Expands Market Opportunity
    • Rise in Aquaculture and Poultry Farming Drives Vaccine Usage in Intensive Farming Systems
    • Growing Threat of Antimicrobial Resistance (AMR) Promotes Preventive Veterinary Care
    • Expansion of Livestock Production in Emerging Economies Drives Adoption of Tailored Vaccines
    • Emergence of Specialized Contract Manufacturing Organizations (CMOs) Supports Market Scalability
    • Government Support for Veterinary Health Infrastructure Spurs Demand for Custom Vaccination
    • Ethical and Regulatory Pressures on Large-Scale Antibiotic Use Fuel Market Momentum
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Autogenous Vaccines Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bacterial Strain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Bacterial Strain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Virus Strain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Virus Strain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Veterinary Clinics & Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Veterinary Clinics & Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Veterinary Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Veterinary Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Livestock Farming Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Livestock Farming Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Poultry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Swine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fish by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Fish by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Horses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Horses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • JAPAN
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • CHINA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • EUROPE
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • FRANCE
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • GERMANY
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • UNITED KINGDOM
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • AUSTRALIA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • INDIA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • LATIN AMERICA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • MIDDLE EAST
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • AFRICA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030

IV. COMPETITION